Post-COVID-19 lung Fibrosis: Imaging Characteristics and Differentiation from Fibrosing ILDs
Keywords:
Post-COVID-19 lung fibrosis; FILD; HRCT; subpleural sparingAbstract
Background: Background: Lung fibrosis is a progressive and irreversible disease that impairs lungs’ function. The globalimpact of COVID-19 lung infection has brought attention to fibrotic lung disease. Post-COVID-19 lung fibrosis is animportant long-term complication that tend to occur in patients with prolonged ICU stays, mechanical ventilation, orcomorbidities. Differentiation of post-COVID-19 lung fibrosis from other fibrosing interstitial lung diseases (FILDs) suchas idiopathic pulmonary fibrosis (IPF),
References
Mandal S, Balas VE, Shaw RN, Ghosh A. Prediction analysis of idiopathic pulmonary fibrosis progression from OSIC dataset. In: 2020 IEEE International Conference on Computing, Power and Communication Technologies (GUCON). IEEE; 2020:861-865.
King TE Jr, Bradford WZ, Castro-Bernardini S, et al. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N Engl J Med. 2014;370:2083-2092
